简介内容：JS25 is a selective, covalent BTK inhibitor that deactivates BTK by chelating Tyr551, exhibiting an IC50 of nM. It suppresses cancer cell proliferation, induces pronounced cell death, and enhances Burkitt´s lymphoma murine xenograft model outcomes. Importantly, JS25 efficiently penetrates the blood-brain barrier.
Customer Service
